Electromed, Inc. Announces Upcoming Earnings Conference Call
Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a prominent player in innovative airway clearance technologies, is set to disclose its financial outcomes for the fiscal 2025 second quarter. This period concluded on December 31, during 2024. The announcement will occur on February 11, 2025, after the markets close, revealing key insights into the company's performance.
Details of the Financial Results Call
Company management will actively engage stakeholders during a conference call scheduled for the same date at 5:00 p.m. Eastern Time. This call provides a platform for interested individuals to delve into the financial details, operational highlights, and future prospects of Electromed.
How to Join the Call
For those eager to participate in this informative session, they can dial (844) 826-3033 for domestic participants or (412) 317-5185 for international callers. These numbers ensure that all interested parties can listen in on the significant developments discussed during the financial results presentation.
Live and Recorded Webcast Access
The live webcast of the conference call will be readily accessible through the Investor Relations section of Electromed’s official website. This enhances transparency and provides an avenue for stakeholders to follow Electromed's progress accurately.
Replay Options
For stakeholders unable to tune in live, a replay will be made available by dialing (844) 512-2921 within North America or (412) 317-6671 internationally. Accessing the replay requires the reference of the designated pin number 10196088. Additionally, the online replay will be accessible on the company’s Investor Relations webpage.
About Electromed, Inc.
Established in 1992 and headquartered in New Prague, Electromed, Inc. specializes in developing products that deliver airway clearance therapy, aiding patients with compromised respiratory functions. Among its innovative offerings is the SmartVest® Airway Clearance System, known for enhancing patient outcomes in airway management.
Company Vision and Market Impact
Electromed is dedicated to advancing airway clearance treatment, enriching the quality of life for countless patients battling lung conditions. By leveraging their unique technologies, they contribute significantly to the healthcare landscape, promoting better respiratory health.
Frequently Asked Questions
What is the purpose of the upcoming conference call?
The conference call aims to discuss Electromed's financial results for its second quarter of fiscal 2025 and share future outlooks.
How can I join the financial results conference call?
Interested parties can join the call by dialing the provided phone numbers for domestic and international participants.
Will there be a method to access a recording of the call?
Yes, a replay will be available for those who cannot attend the live call, accessible via phone and online methods.
What products does Electromed manufacture?
Electromed, Inc. manufactures airway clearance systems, notably the SmartVest® Airway Clearance System, designed for patients with pulmonary issues.
When will the financial results be announced?
The financial results will be announced on February 11, 2025, after market closing.